Switch theme
Sign up to access all valuation multiples
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
1993
1.5K+
LTM Revenue $1.2B
LTM EBITDA -$45.2M
$532M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
DocMorris has a last 12-month revenue of $1.2B and a last 12-month EBITDA of -$45.2M.
In the most recent fiscal year, DocMorris achieved revenue of $1.2B and an EBITDA of -$42.6M.
DocMorris expects next 12-month revenue of XXX and NTM EBITDA of XXX
See DocMorris valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | XXX | XXX | XXX |
| Gross Profit | $278M | $230M | XXX | XXX | XXX |
| Gross Margin | 25% | 20% | XXX | XXX | XXX |
| EBITDA | -$63.4M | -$42.6M | XXX | XXX | XXX |
| EBITDA Margin | -6% | -4% | XXX | XXX | XXX |
| Net Profit | -$193M | $93.0M | XXX | XXX | XXX |
| Net Margin | -18% | 8% | XXX | XXX | XXX |
| Net Debt | $412M | $281M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, DocMorris's stock price is CHF 21 (or $24).
DocMorris has current market cap of CHF 253M (or $286M), and EV of CHF 470M (or $532M).
See DocMorris trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $532M | $286M | XXX | XXX | XXX | XXX | $-8.31 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, DocMorris has market cap of $286M and EV of $532M.
DocMorris's trades at 0.4x LTM EV/Revenue multiple, and -11.8x LTM EBITDA.
Analysts estimate DocMorris's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for DocMorris and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $532M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | -12.5x | XXX | XXX | XXX |
| P/E | -2.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -8.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDocMorris's NTM/LTM revenue growth is 18%
DocMorris's revenue per employee for the last fiscal year averaged $0.8M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, DocMorris's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate DocMorris's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for DocMorris and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -4% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -33% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 14% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.8M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DocMorris acquired XXX companies to date.
Last acquisition by DocMorris was XXXXXXXX, XXXXX XXXXX XXXXXX . DocMorris acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was DocMorris founded? | DocMorris was founded in 1993. |
| Where is DocMorris headquartered? | DocMorris is headquartered in Switzerland. |
| How many employees does DocMorris have? | As of today, DocMorris has 1.5K+ employees. |
| Is DocMorris publicy listed? | Yes, DocMorris is a public company listed on SWX. |
| What is the stock symbol of DocMorris? | DocMorris trades under DOCM ticker. |
| When did DocMorris go public? | DocMorris went public in 2017. |
| Who are competitors of DocMorris? | Similar companies to DocMorris include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of DocMorris? | DocMorris's current market cap is $286M |
| What is the current revenue of DocMorris? | DocMorris's last 12-month revenue is $1.2B. |
| What is the current EBITDA of DocMorris? | DocMorris's last 12-month EBITDA is -$45.2M. |
| What is the current EV/Revenue multiple of DocMorris? | Current revenue multiple of DocMorris is 0.4x. |
| What is the current EV/EBITDA multiple of DocMorris? | Current EBITDA multiple of DocMorris is -11.8x. |
| What is the current revenue growth of DocMorris? | DocMorris revenue growth between 2023 and 2024 was 5%. |
| Is DocMorris profitable? | Yes, DocMorris is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
